#bioreactor scaling

Discover 1 curated intelligence briefings related to this specific topic.

MEMBRANE DISTILLATION AND BIOREACTOR EXPANSION SECURE HIGH-PURITY API STANDARDS

The pharmaceutical industry has reached a critical inflection point in July 2026. Peptistar's scaling of Asahi Kasei's FO-MD system and Bora Pharmaceuticals' acquisition of MacroGenics' Rockville operations signal a move toward heat-free concentration and consolidated biologics hubs.

Read Analysis